-
EP3318565
European procedure
Extract from the Register of European Patents
EP About this file: EP3318565
| EP3318565 - PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.02.2022 Database last updated on 30.10.2024 | |
| Former | The patent has been granted Status updated on 12.03.2021 | ||
| Former | Grant of patent is intended Status updated on 13.12.2020 | ||
| Former | Examination is in progress Status updated on 17.11.2020 | ||
| Former | Grant of patent is intended Status updated on 20.07.2020 | ||
| Former | Examination is in progress Status updated on 01.07.2019 | ||
| Former | Request for examination was made Status updated on 16.11.2018 | ||
| Former | The application has been published Status updated on 06.04.2018 | Most recent event Tooltip | 15.07.2022 | Lapse of the patent in a contracting state New state(s): MC | published on 17.08.2022 [2022/33] | Applicant(s) | For all designated states Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US | [2018/19] | Inventor(s) | 01 /
BROWN, Matthew Frank 443 Wheeler Road Stonington, CT Connecticut 06378 / US | 02 /
CASIMIRO-GARCIA, Agustin 61 Woodland Road Concord, MA Massachusetts 01742 / US | 03 /
CHE, Ye 166 Ledgewood Road Apartment 308 Groton, CT Connecticut 06340 / US | 04 /
COE, Jotham Wadsworth 8 Bush Hill Drive Niantic, CT Connecticut 06357 / US | 05 /
FLANAGAN, Mark Edward 10 Queen Eleanor Drive Gales Ferry, CT Connecticut 06335 / US | 06 /
GILBERT, Adam Matthew 178 Denison Drive Guilford, CT Connecticut 06437 / US | 07 /
HAYWARD, Matthew Merrill 3 Pyrus Court Old Lyme, CT Connecticut 06371 / US | 08 /
LANGILLE, Jonathan David 15 Clark Place Quaker Hill, CT Connecticut 06375 / US | 09 /
MONTGOMERY, Justin Ian 61 Spicer Hill Road Ledyard, CT Connecticut 06339 / US | 10 /
TELLIEZ, Jean-Baptiste 211 East Emerson Road Lexington, MA Massachusetts 02420 / US | 11 /
THORARENSEN, Atli 581 Great Road Stow, MA Massachusetts 01775 / US | 12 /
UNWALLA, Rayomand Jal 22 Fox Run Road Bedford, MA Massachusetts 01730 / US | 13 /
TRUJILLO, John I 33 Saw Mill Drive Ledyard, CT Connecticut 06339 / US | [2018/19] | Representative(s) | Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR | [2018/19] | Application number, filing date | 17200940.9 | 20.11.2014 | [2018/19] | Priority number, date | US201361912074P | 05.12.2013 Original published format: US 201361912074 P | [2018/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3318565 | Date: | 09.05.2018 | Language: | EN | [2018/19] | Type: | B1 Patent specification | No.: | EP3318565 | Date: | 14.04.2021 | Language: | EN | [2021/15] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.02.2018 | Classification | IPC: | C07D471/04, C07D487/04, A61K31/4375, A61P35/00 | [2018/19] | CPC: |
C07D471/04 (EP,CN,IL,KR,MX,US);
C07D487/04 (EP,CN,IL,KR,MX,US);
A61K31/4375 (IL,KR);
A61K31/4523 (US);
A61K31/519 (IL,KR);
A61P1/00 (EP,IL);
A61P1/04 (EP,IL);
A61P1/16 (EP,IL);
A61P1/18 (EP,IL);
A61P11/00 (EP,IL);
A61P11/06 (EP,IL);
A61P11/08 (EP,IL);
A61P13/12 (EP,IL);
A61P15/08 (EP,IL);
A61P17/00 (EP,IL);
A61P17/02 (EP,IL);
A61P17/04 (EP,IL);
A61P17/06 (EP,IL);
A61P17/14 (EP,IL);
A61P19/02 (EP,IL);
A61P19/04 (EP,IL);
A61P21/00 (EP,IL);
A61P21/04 (EP,IL);
A61P25/00 (EP,IL);
A61P25/08 (EP,IL);
A61P25/14 (EP,IL);
A61P25/16 (EP,IL);
A61P25/18 (EP,IL);
A61P25/22 (EP,IL);
A61P25/24 (EP,IL);
A61P25/28 (EP,IL);
A61P27/02 (EP,IL);
A61P29/00 (EP,IL);
A61P3/00 (EP,IL);
A61P3/10 (EP,IL);
A61P35/00 (EP,IL);
A61P35/02 (EP,IL);
A61P37/02 (EP,IL);
A61P37/06 (EP,IL);
A61P37/08 (EP,IL);
A61P43/00 (EP,IL);
A61P5/14 (EP,IL);
A61P7/00 (EP,IL);
A61P7/04 (EP,IL);
A61P7/06 (EP,IL);
A61P9/00 (EP,IL);
A61P9/10 (EP,IL);
C07D471/08 (EP,IL,KR,MX,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/51] |
| Former [2018/19] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 09.11.2018 | ME | 09.11.2018 | Title | German: | PYRROLO[2,3-D]PYRIMIDINYL-, PYRROLO[2,3-B]PYRAZINYL- UND PYRROLO[2,3-D]PYRIDINYL-ACRYLAMID | [2018/19] | English: | PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES | [2018/19] | French: | PYRROLO[2,3-D]PYRIMIDINYLE, PYRROLO[2,3-B]PYRAZINYLE ET PYROLLO[2,3-D]PYRIDINYLE ACRYLAMIDES | [2018/19] | Examination procedure | 06.11.2018 | Amendment by applicant (claims and/or description) | 09.11.2018 | Examination requested [2018/51] | 09.11.2018 | Date on which the examining division has become responsible | 04.07.2019 | Despatch of a communication from the examining division (Time limit: M06) | 14.02.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 28.02.2020 | Reply to a communication from the examining division | 21.07.2020 | Communication of intention to grant the patent | 17.11.2020 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 14.12.2020 | Communication of intention to grant the patent | 01.03.2021 | Fee for grant paid | 01.03.2021 | Fee for publishing/printing paid | 01.03.2021 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP14816404.9 / EP3077395 | Opposition(s) | 17.01.2022 | No opposition filed within time limit [2022/12] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 28.02.2020 | Request for further processing filed | 28.02.2020 | Full payment received (date of receipt of payment) Request granted | 19.03.2020 | Decision despatched | Fees paid | Renewal fee | 09.03.2018 | Renewal fee patent year 03 | 09.03.2018 | Renewal fee patent year 04 | 30.11.2018 | Renewal fee patent year 05 | 02.12.2019 | Renewal fee patent year 06 | 30.11.2020 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 14.04.2021 | SM | 14.04.2021 | [2022/33] |
| Former [2022/07] | SM | 14.04.2021 | Documents cited: | Search | [AD]WO9965909 (PFIZER PROD INC [US], et al); | [AD]WO0200661 (PFIZER PROD INC [US], et al) | by applicant | WO9965908 | WO9965909 | WO0142246 | WO0200661 | WO02096909 | WO2004046112 | WO2007012953 | WO2010016005 | WO2010063634 | WO2011002904 | WO2011029046 | WO2011101161 |